SEC Form 4/A · accession 0001288123-16-000067
AGENUS INC · AGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Garo H Armen
Officer — Chairman & CEO
Period of report
May 6, 2016
Accepted (ET)
May 10, 2016 · 9:49 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001098972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 6, 2016 | P | 50,000 | $3.0792 | A | 1,346,026 | D | |
| Common Stock | May 9, 2016 | P | 50,000 | $3.2787 | A | 1,396,026 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Form 4/A filed to correct an incorrect transaction date previously reported.
- F2This Form 4 reports the purchase, by Dr. Armen, of 100,000 shares of Agenus Inc. common stock. Of the 100,000 shares purchased by Dr. Armen and reported herein, 19,576 shares were matchable under Section 16(b) of the Securities Exchange Act of 1934 with Dr. Armen's sale of an equivalent number of shares of Agenus common stock at a weighted average price of $4.5715 per share on December 29, 2015. Dr. Armen has paid to Agenus, as of May 9, 2016, $27,714.24, representing the full amount of the profit realized in connection with the short-swing transaction.